|
会议详情 |
|
推荐会议：未来工厂30人论坛
发票类型：增值税普通发票 增值税专用发票
实验室自动化与筛选协会2015亚洲年会将于2015年4月9日-10日在上海浦东康桥加入酒店召开。作为推动科学与技术相结合的平台，SLAS聚集了来自全球的18000名生命科学领域的研发精英，包括科学家、技术提供商、研究人员、学术人员和学生、工程师、信息学专家以及商业领袖。SLAS组织并提供全年的教育和交流活动，致力于为全球科学和技术领域的专业人员建立联系并达成合作创新。
第四届SLAS亚洲会展将于2015年4月9日-10日在上海世纪皇冠假日酒店举行。本届大会主题为“Come Transform Research”。中科院院士高福、饶子和、王晓东等多位学术界知名科学家携手跨国药企、CRO和技术服务企业的科研人员及高管，担任本届大会演讲嘉宾。他们将从小分子、天然产物、大分子等不同角度出发，和参会者共同探讨新药发现的最新研究成果及技术创新。内容包含靶标确认、高通量筛选、转化医学、抗体研究等热门主题。多样化的研究领域和方向将使得本次大会精彩纷呈。
本届大会不仅从多元化角度为参会者们呈现新药发现领域的前沿科学性内容。同时，还将以实例跟大家分享学术产业界的合作如何促进科学研究成果的转化。在为期两天的同期展会中，三十多家跨国公司将展示最新实验室自动化仪器和相关技术。本届大会也是SLAS与生物医药创新社的首次合作，其2015年会将于4月10日同期召开。
会议亮点
——Frontier scientific programs present different approaches to drug discovery from small molecules to biologics
——Emphasize the connection between academia and Industries to advance the commercialization of scientific findings
——Over 30 multinational companies showcase the latest laboratory technologies
——Special Session: Biologics Innovation Group 2015 Annual Conference
时间地点
会议时间：2015年4月9-10日
会议地点：上海
参会费用：1月28日前，650元/人；1月28日之后，800元/人；标准价格 1000元/人。
| 4月9日 星期四 | |
| 08:4509:00 | SLAS Opening Remarks |
| 09:00-09:45 | Keynote 1: Going Fishing for Better Medicines Karl Barry Sharpless, Nobel Prize Laureate, W. M. Keck Professor of Chemistry, The Scripps Research Institute, California |
| 09:45-12:45 | Session 1: Leading Science for Small Molecules Drug Discovery Co-chairs: Jonathan Connick, Executive Director, Head External in Vitro Pharmacology. Site Head, EDDS and PCD China, Merck & Co Inc., Member of SLAS Asia Council Bin Li, R&D Director, AbbVie China R&D Center, Secretary of SLAS Asia Council |
| 09:45-10:15 | Topic tbc Xin Xie, SIMM |
| 10:15-10:45 | Phenotypic Drug Discovery and Target Deconvolution Jing Li, Director of Pharmacology; Department of Screening and Protein Science; Merck Research Laboratories (MRL) |
| 10:45-11:15 | Break in Exhibit Hall |
| 11:15-11:45 | Discovery of HIV Integrase Inhibitors John Wai, Vice President of Medicinal Chemistry, WuXi AppTec (Shanghai) |
| 11:45-12:45 | Panel Discussion：Leveraging Technology and Tools to Enable Drug Discovery Moderator: Jonathan Connick, Executive Director, Head External in Vitro Pharmacology. Site Head, EDDS and PCD China, Merck & Co., Inc., Member of SLAS Asia Council Panelist: Pharma – Jing Li, Director of Pharmacology; Department of Screening and Protein Science; Merck Research Laboratories (MRL) CRO - Xuehai Tan, CEO & President, HD Biosciences Co., Ltd. Technology Provider - Joe Gu, LST APAC VP GM, Perkin Elmer Academia – Jian Li / Xin Xie - tbc |
| 12:45_14:30 | Lunch in Exhibit Hall |
| 12:45-14:30 | Posters |
| 13:30-14:15 | Exhibitor Tutorial 1 Exhibitor Tutorial 2 |
| 14:30-17:00 | Session 2: Natural Product Drug Discovery & Synthetic Biology Co-chairs: Bing Xie, Managing Director, Asia Pacific for Cisbio Bioassays, Member of SLAS Asia Council Mike Zhang, Associate Sales Director, Research, BD Biosciences, Member of SLAS Asia Council |
| 14:30-15:00 | Discovery of NITD609 as Antimalarial: From Natural Product-like Lead to Clinical Candidate Bin Zou, Senior Medicinal Chemist, Novartis Institute for Tropical Diseases (Singapore) |
| 15:00-15:30 | HTS Hits - Which Should You Discard, and Why? Jonathan Baell, Research Professor, Medicinal Chemistry, Monash Institute of Pharmaceutical Science |
| 15:30-16:00 | Break in Exhibit Hall |
| 16:00-16:30 |
Anti-infective and Anti-tumor Natural Products Discovery and Biosynthesis from Marine Actinomycetes |
| 16:30-17:00 | Anti-infectious Natural Products from Marine-derived Microbes Xueting Liu, Associate Professor , CAS Key Laboratory of Pathogenic Microbiology & Immunology |
| 17:00-17:30 | Topic tbc Hakim Djaballah - tbc |
| 17:30-19:00 | Reception |
| 4月10日 星期五 Biologics Innovation Group 2015 Annual Conference | |
| 08:45-09:00 | Welcome Speech- Biologics Enabling Working Group Annual Conference Bill Jiang, Director, Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University |
| 09:00-09:45 | Keynote 2 : Vaccine and Therapeutic Antibody for New Outbreak of Pathogen Fu Gao, Vice President, Beijing Institutes of Life Science, Chinese Academy of Sciences; Director, CAS Key Laboratory of Pathogenic Microbiology and Immunology, Institute of Microbiology; Professor, University of Science and Technology of China |
| 09:45-12:30 | Session 3: The Scientific Frontier of Biological Discovery |
| Part I | Co-chairs: Ying Yang, Founder & CEO, LBD Life Sciences Ltd; Asia Council Chair, Society for Laboratory Automation and Screening (SLAS) Bill Jiang, Director, Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University |
| 09:45-10:15 | Virus and Anti-Virus Drug Discovery Zihe Rao, Biophysicist & Structural Biologist; Professor & Former President, Nankai University; Academician, Chinese Academy of Sciences; President, Biophysical Society of China; President, International Union of Pure and Applied Biophysics (IUPAB) |
| 10:15-10:45 | Break in Exhibit Hall |
| Part II | Co-Chairs: Guang Yang, Vice Director, Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University Mingqiang Zhang, Vice President, R&D for China Amgen |
| 10:45-11:15 | Systems Approach to Translational Medicine Genhong Cheng, Director, Suzhou Institute of Systems Medicine, Chinese Academy of Medical Sciences; Professor, Department of Microbiology, Immunology & Molecular Genetics, UCLA |
| 11:15-11:45 | Therapeutic Antibody Discovery and Lead Selection Yan Wu, Associate Director, Genentech |
| 11:45-12:30 | Feature Talk and Panel Discussion: Case Study-NIBS’s Technology Transfer and Commercialization of Scientific Findings Moderator: Chengbin Wu, CSO and President of R&D, Shanghai CP Guojian Pharmaceutical Co., Ltd. Speaker: Xiaodong Wang, Biochemist; Director & Investigator, National Institute of Biological Science, China; Member, National Academy of Sciences, USA Panelist: Mingqiang Zhang, Vice President of R&D for China Amgen Yajun Xu, President of Shangpharma Investment; Executive Vice President, Shanghai Chempartner Bill Jiang, Director, Shanghai Institute for Advanced Immunochemical Studies, ShanghaiTech University |
| 12:30-14:00 | Lunch in Exhibit Hall |
| 12:30-14:00 | Posters |
| 13:15-14:00 | Exhibitor Tutorial 3: Location: Nanjing Room, Level 5 Sponsored by Exhibitor Tutorial 4: Location：Suzhou Room, Level 5 |
| 14:00-17:30 | Session 4: ADC - From Technology, Process, Discovery to Development (To be confirmed) |
| Part I | Co-chairs: Xueming Qian, Chairman & CEO, Mabspace Biosciences CO., LTD Yajun Xu, President of Shangpharma Investment; Executive Vice President, Shanghai Chempartner |
| 14:00-14:30 | Antibody-Drug Conjugates for Cancer Therapy: Strategies and Perspectives Weikang Tao, CSO, Hengrui Pharmaceutical R&D |
| 14:30-15:00 | Site Specific Conjugation: Improvement of ADC Homogeneity and Druggability Properties Bruce Nianhe Han, CSO, NewBio Therapeutics |
| 15:00-15:30 | R&D of Next-generation ADCs Based on LDC Technology Gang Qin, CEO, GeneQuantum Healthcare (Suzhou) Co., Ltd. |
| 15:30-16:00 | Biological Characterization of Antibody Drug Conjugates Mary Hu, CEO, Shanghai Miracogen Inc |
| 16:00-16:30 | Break in Exhibit Hall |
| Part II | Co-chairs: Zhenping Zhu, Executive Vice President, Global Biopharmaceuticals, Kadmon Corporation (New York); President, Kadmon China Chengbin Wu, CSO and President of R&D, Shanghai CP Guojian Pharmaceutical Co., Ltd. |
| 16:30-17:00 | A New Generation of Antibody-drug Conjugates for the Targeted Treatment of Cancer Robert Yongxin Zhao, CEO & Chairman, Hangzhou DAC Biotech Co., Ltd. |
| 17:00-17:30 | Developing a Novel ADC for Global Market via Innovative Three-party Collaboration Chris Chen, Head of Biologics, Wuxi Apptec |
| 17:30-17:45 | Closing Remark (awarding) |
|
Karl Barry Sharpless, Ph.D |
Fu Gao, PhD, MCAS |
|
Zihe Rao, PhD, MCAS |
Xiaodong Wang, PhD, MNAS |
相关会议
商务会议
会议嘉宾
会议主办方
会议场地
会议PPT
APP参会
订单查询
开通会员
2015-04-09 08:00 至 2015-04-10 18:00
